News

Gujarat Kidney and Super Speciality Limited announced the appointment of Mrs. (Dr) Disha Bharpoda (DIN: 11897794) as an Additional Non-Executive Independent Director, effective August 24, 2026, following a board meeting held on the same date. The appointment is for a term of five years and is subject to approval by the company`s members at the next Annual General Meeting. Additionally, the board acknowledged shareholder approval via postal ballot for a special resolution concerning a variation in the objects and terms of utilization of the Initial Public Offering proceeds.

Gujarat Kidney & Super Speciality will hold a meeting of the Board of Directors of the Company on 14 August 2026.

Net profit of Gujarat Kidney & Super Speciality rose 293.75% to Rs 5.04 crore in the quarter ended March 2026 as against Rs 1.28 crore during the previous quarter ended March 2025. Sales rose 212.68% to Rs 30.58 crore in the quarter ended March 2026 as against Rs 9.78 crore during the previous quarter ended March 2025.For the full year,net profit rose 64.72% to Rs 15.50 crore in the year ended March 2026 as against Rs 9.41 crore during the previous year ended March 2025. Sales rose 103.80% to Rs 82.01 crore in the year ended March 2026 as against Rs 40.24 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales30.589.78 213 82.0140.24 104 OPM %20.6026.79 -32.8541.13 - PBDT6.192.50 148 25.9316.06 61 PBT4.691.60 193 21.2312.77 66 NP5.041.28 294 15.509.41 65 Powered by Capital Market - Live News

Gujarat Kidney & Super Speciality will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Gujarat Kidney & Super Speciality has postponed the meeting of the Board of Directors which was scheduled to be held on 13 February 2026. The meeting will now be held on 14 February 2026.Powered by Capital Market - Live News